UK markets closed

Orphazyme A/S (0CUM.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
0.9860-0.2660 (-21.25%)
At close: 10:07AM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 340.36%
S&P500 52-week change 323.06%
52-week high 31.2520
52-week low 30.0000
50-day moving average 30.9226
200-day moving average 30.9226

Share statistics

Avg vol (3-month) 385
Avg vol (10-day) 32.78k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 810.42k
% held by insiders 140.44%
% held by institutions 17.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-21.15%
Return on equity (ttm)-94.35%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.1M
Net income avi to common (ttm)-26.05M
Diluted EPS (ttm)-17.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.21M
Total cash per share (mrq)515.77
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.81
Book value per share (mrq)403.32

Cash flow statement

Operating cash flow (ttm)-20.02M
Levered free cash flow (ttm)-1.8M